期刊文献+

如何选择对肾脏功能有保护作用的钙拮抗剂

原文传递
导出
摘要 高血压是临床常见病、多发病,已成为多种心脑血管疾病发生发展的主要危险因素之一。高血压病以血压升高为特点,动脉压持续性升高,会引发全身小动脉硬化,影响心、肾、脑等组织器官的血液供应,造成器官损害。因此,选择一种能够有效降压、同时对靶器官有保护作用的药物至关重要[1]。在所有的降压药物中钙拮抗剂降压作用迅速而强力.
出处 《首都食品与医药》 2019年第11期5-6,共2页 Capital Food Medicine
  • 相关文献

参考文献3

二级参考文献43

  • 1ISHII A,TOYAMA J. Binding properties of (+/-) [ 3H] benidipine hydrochloride to rat heart membranes [ J ]. J Cardiovasc Pharmacol, 1993,21 ( 2 ) : 191 - 196.
  • 2KARASAWA A,KUBO K. Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries[ J]. Jpn J Pharmacol, 1988,47 (5) :35-44.
  • 3KODAMA S, INOUE Y, MIHARO H, et al. Prognostic factors for the long-term survival in patients with vasospastic angina. Analysis of effect of patients' characteristics and therapeutic drugs [ J]. J Cardiol,2009,54( 1 ) :10-20.
  • 4FUMIO K. Study of the therapeutic usefulness of benidipine hydrochloride (Coniel) in elderly angina pectoris patient s[ J]. Jpn J Clin Exp Med, 1998,75(8) :199-201.
  • 5MATSUBARA M, YAO K, HASEGAWA K. Benidipine, a dihydropyridine-calcium channel blocker, inhibits lysophosphatidylcholine-induced endothelial injury via stimulation of nitric oxide release [J]. Pharmacol Res ,2006,53 ( 1 ) :3543.
  • 6TETSUO O. Evaluation of the clinical effects and the safety of benidipine hydrochloride (KW-3049) in long term administration on the patients with angina pectoris [ J ]. Jap Pharm Ther, 1990,18 (Suppl4) :211-215.
  • 7TETSUO O. Evaluation of the clinical effects and the safety of benidipine hydrochloride ( KW-3049 ) in long term administration on the patients with angina pectoris [ J ]. Jap Pharm Ther, 1990,18 (Supp14) :211-215.
  • 8FULUKAWA T, YAMAKAWA T. Seleetivities of dihydropyridine derivatives in blocking Ca2+ channel subtypes expressed in xenopusoocytes [ J]. J Pharmacol Exp Ther, 1999,291 (2) :464-468.
  • 9Roman M J, Devereux RB, Kizer JR, Okin PM, Lee ET, Wang W, et al. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol 2009; 54: 1730-1734.
  • 10Tomlinson LA, Wilkinson IB. Does it matter where we measure blood pressure? Br J Clin Pharmaco12012; 74: 241-245.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部